• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies. 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.

    View/Open
    Accepted version (15.06Kb)
    Volume
    33
    DOI
    10.1200/jco.2015.33.15_suppl.2514
    Issue
    15
    ISSN
    0732-183X
    Metadata
    Show full item record
    Authors
    Blagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P; Patel, M; Sukumaran, A; Loyse, N; Bharwani, N; Rockall, A
    URI
    http://meeting.ascopubs.org/cgi/content/short/33/15_suppl/2514
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/12316
    Collections
    • Centre for Haemato-Oncology [167]
    Copyright statements
    © 2015 American Society of Clinical Oncology
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.